|
Unitedhealth Group Common
(UNH)
|
4.1 |
$126M |
|
316k |
400.44 |
|
Amgen Common
(AMGN)
|
3.7 |
$113M |
|
463k |
243.75 |
|
Gilead Sciences Common
(GILD)
|
3.7 |
$113M |
|
1.6M |
68.86 |
|
Moderna Common
(MRNA)
|
3.6 |
$109M |
|
466k |
234.98 |
|
Illumina Common
(ILMN)
|
3.1 |
$96M |
|
202k |
473.21 |
|
Horizon Therapeutics Shares
|
2.8 |
$88M |
|
936k |
93.64 |
|
Abbott Laboratories Common
(ABT)
|
2.8 |
$87M |
|
751k |
115.93 |
|
Johnson & Johnson Common
(JNJ)
|
2.8 |
$85M |
|
517k |
164.74 |
|
Vertex Pharmaceuticals Common
(VRTX)
|
2.6 |
$80M |
|
395k |
201.63 |
|
Regeneron Pharmaceuticals Common
(REGN)
|
2.5 |
$77M |
|
138k |
558.54 |
|
Biogen Common
(BIIB)
|
2.4 |
$72M |
|
209k |
346.27 |
|
Thermo Fisher Scientific Common
(TMO)
|
2.3 |
$71M |
|
140k |
504.47 |
|
AbbVie Common
(ABBV)
|
2.3 |
$70M |
|
617k |
112.64 |
|
Medtronic Shares
(MDT)
|
2.2 |
$68M |
|
547k |
124.13 |
|
Eli Lilly and Common
(LLY)
|
1.9 |
$59M |
|
257k |
229.52 |
|
Cigna Corp. Common
(CI)
|
1.6 |
$50M |
|
211k |
237.07 |
|
Danaher Corp. Common
(DHR)
|
1.4 |
$45M |
|
166k |
268.36 |
|
Bristol-Myers Squibb Common
(BMY)
|
1.4 |
$44M |
|
656k |
66.82 |
|
Merck & Co Common
(MRK)
|
1.4 |
$42M |
|
542k |
77.77 |
|
Anthem Common
(ELV)
|
1.3 |
$41M |
|
108k |
381.80 |
|
Stryker Corp. Common
(SYK)
|
1.3 |
$39M |
|
151k |
259.73 |
|
Zimmer Biomet Holdings Common
(ZBH)
|
1.2 |
$36M |
|
223k |
160.82 |
|
Dexcom Common
(DXCM)
|
1.1 |
$35M |
|
83k |
427.00 |
|
ResMed Common
(RMD)
|
1.1 |
$34M |
|
138k |
246.52 |
|
Seagen Common
|
1.1 |
$33M |
|
211k |
157.88 |
|
McKesson Corp. Common
(MCK)
|
0.9 |
$29M |
|
151k |
191.24 |
|
AstraZeneca Sponsored ADR
(AZN)
|
0.9 |
$27M |
|
448k |
59.90 |
|
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.9 |
$26M |
|
162k |
161.89 |
|
HCA Healthcare Common
(HCA)
|
0.8 |
$26M |
|
125k |
206.74 |
|
Humana Common
(HUM)
|
0.8 |
$26M |
|
58k |
442.73 |
|
United Therapeutics Corp. Class B
(UTHR)
|
0.8 |
$25M |
|
139k |
179.41 |
|
Exact Sciences Corp. Common
(EXAS)
|
0.8 |
$25M |
|
200k |
124.31 |
|
Dentsply Sirona Common
(XRAY)
|
0.8 |
$24M |
|
382k |
63.26 |
|
Health Care Select Sector SPDR Fund SBI Healthcare
(XLV)
|
0.8 |
$24M |
|
189k |
125.95 |
|
Edwards Lifesciences Corp. Common
(EW)
|
0.7 |
$23M |
|
222k |
103.57 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
0.7 |
$23M |
|
135k |
169.52 |
|
argenx SE Sponsored ADR
(ARGX)
|
0.7 |
$22M |
|
74k |
301.08 |
|
IDEXX Laboratories Common
(IDXX)
|
0.7 |
$22M |
|
35k |
631.56 |
|
Syneos Health Class A
|
0.7 |
$22M |
|
244k |
89.49 |
|
Neurocrine Biosciences Common
(NBIX)
|
0.7 |
$21M |
|
213k |
97.32 |
|
Charles River Laboratories International Common
(CRL)
|
0.7 |
$20M |
|
55k |
369.92 |
|
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.7 |
$20M |
|
154k |
131.55 |
|
Guardant Health Common
(GH)
|
0.6 |
$20M |
|
159k |
124.19 |
|
Intuitive Surgical Common
(ISRG)
|
0.6 |
$20M |
|
21k |
919.66 |
|
Laboratory Corp. of America Holdings Sponsored ADR
|
0.6 |
$19M |
|
70k |
275.85 |
|
Novavax Common
(NVAX)
|
0.6 |
$19M |
|
88k |
212.32 |
|
Pfizer Common
(PFE)
|
0.6 |
$18M |
|
450k |
39.16 |
|
Welltower Common
(WELL)
|
0.5 |
$17M |
|
203k |
83.10 |
|
Waters Corp. Common
(WAT)
|
0.5 |
$17M |
|
48k |
345.61 |
|
Molina Healthcare Common
(MOH)
|
0.5 |
$16M |
|
64k |
253.06 |
|
BeiGene Sponsored ADR
(ONC)
|
0.5 |
$16M |
|
46k |
343.19 |
|
Sarepta Therapeutics Common
(SRPT)
|
0.5 |
$15M |
|
193k |
77.74 |
|
Adaptive Biotechnologies Corp. Common
(ADPT)
|
0.4 |
$14M |
|
338k |
40.86 |
|
IQVIA Holdings Common
(IQV)
|
0.4 |
$14M |
|
57k |
242.33 |
|
G1 Therapeutics Common
|
0.4 |
$14M |
|
624k |
21.94 |
|
I-Mab Sponsored ADS
(IMAB)
|
0.4 |
$14M |
|
163k |
83.95 |
|
Mettler-Toledo International Common
(MTD)
|
0.4 |
$14M |
|
9.8k |
1385.31 |
|
Mirati Therapeutics Common
|
0.4 |
$14M |
|
84k |
161.53 |
|
Arena Pharmaceuticals Common
|
0.4 |
$13M |
|
196k |
68.20 |
|
Ionis Pharmaceuticals Common
(IONS)
|
0.4 |
$13M |
|
323k |
39.89 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.4 |
$13M |
|
135k |
95.35 |
|
BioNTech SE Sponsored ADS
(BNTX)
|
0.4 |
$13M |
|
57k |
223.89 |
|
Novartis Sponsored ADR
(NVS)
|
0.4 |
$12M |
|
136k |
91.24 |
|
CVS Health Corp. Common
(CVS)
|
0.4 |
$12M |
|
148k |
83.44 |
|
Iovance Biotherapeutics Common
(IOVA)
|
0.4 |
$12M |
|
469k |
26.02 |
|
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.4 |
$12M |
|
68k |
177.64 |
|
Ventas Common
(VTR)
|
0.4 |
$12M |
|
208k |
57.10 |
|
Alexion Pharmaceuticals Common
|
0.4 |
$12M |
|
65k |
183.72 |
|
Amedisys Common
(AMED)
|
0.4 |
$12M |
|
48k |
244.93 |
|
Denali Therapeutics Common
(DNLI)
|
0.4 |
$12M |
|
150k |
78.44 |
|
BridgeBio Pharma Common
(BBIO)
|
0.4 |
$12M |
|
189k |
60.96 |
|
Karuna Therapeutics Common
|
0.4 |
$12M |
|
101k |
113.99 |
|
Allakos Common
|
0.4 |
$11M |
|
133k |
85.37 |
|
Deciphera Pharmaceuticals Common
|
0.4 |
$11M |
|
308k |
36.61 |
|
Owens & Minor Common
(OMI)
|
0.4 |
$11M |
|
266k |
42.33 |
|
Omega Healthcare Investors Common
(OHI)
|
0.4 |
$11M |
|
306k |
36.29 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.4 |
$11M |
|
133k |
82.82 |
|
Blueprint Medicines Corp. Common
(BPMC)
|
0.4 |
$11M |
|
123k |
87.96 |
|
BioMarin Pharmaceutical Common
(BMRN)
|
0.3 |
$11M |
|
128k |
83.44 |
|
Zoetis Class A
(ZTS)
|
0.3 |
$11M |
|
57k |
186.36 |
|
Becton, Dickinson and Common
(BDX)
|
0.3 |
$11M |
|
43k |
243.19 |
|
Galera Therapeutics Common
(GRTX)
|
0.3 |
$10M |
|
1.0M |
9.83 |
|
Apellis Pharmaceuticals Common
(APLS)
|
0.3 |
$9.6M |
|
153k |
63.20 |
|
Theravance Biopharma Common
(TBPH)
|
0.3 |
$9.5M |
|
656k |
14.52 |
|
Intellia Therapeutics Common
(NTLA)
|
0.3 |
$9.4M |
|
58k |
161.91 |
|
Turning Point Therapeutics Common
|
0.3 |
$9.3M |
|
119k |
78.02 |
|
Sabra Health Care REIT Common
(SBRA)
|
0.3 |
$9.3M |
|
511k |
18.20 |
|
Physicians Realty Trust Common
|
0.3 |
$9.2M |
|
496k |
18.47 |
|
Exelixis Common
(EXEL)
|
0.3 |
$9.1M |
|
500k |
18.22 |
|
Incyte Corp. Common
(INCY)
|
0.3 |
$9.1M |
|
108k |
84.13 |
|
Universal Health Services Class B
(UHS)
|
0.3 |
$8.8M |
|
60k |
146.43 |
|
Catalent Common
|
0.3 |
$8.7M |
|
80k |
108.12 |
|
Replimune Group Common
(REPL)
|
0.3 |
$8.4M |
|
219k |
38.42 |
|
Medical Properties Trust Common
(MPW)
|
0.3 |
$8.3M |
|
412k |
20.10 |
|
Intra-Cellular Therapies Common
(ITCI)
|
0.3 |
$8.3M |
|
203k |
40.82 |
|
ACADIA Pharmaceuticals Common
(ACAD)
|
0.3 |
$8.1M |
|
332k |
24.39 |
|
Boston Scientific Corp. Common
(BSX)
|
0.3 |
$8.0M |
|
186k |
42.76 |
|
Agilent Technologies Common
(A)
|
0.3 |
$7.8M |
|
53k |
147.82 |
|
Affimed Common
|
0.3 |
$7.7M |
|
909k |
8.50 |
|
Icon Shares
(ICLR)
|
0.2 |
$7.5M |
|
36k |
206.70 |
|
Sutro Biopharma Common
(STRO)
|
0.2 |
$7.4M |
|
400k |
18.59 |
|
LTC Properties Common
(LTC)
|
0.2 |
$7.0M |
|
182k |
38.39 |
|
uniQure Shares
(QURE)
|
0.2 |
$7.0M |
|
226k |
30.80 |
|
Y-mAbs Therapeutics Common
|
0.2 |
$6.7M |
|
198k |
33.80 |
|
Zai Lab Adr
(ZLAB)
|
0.2 |
$6.6M |
|
38k |
176.98 |
|
Arvinas Common
(ARVN)
|
0.2 |
$6.6M |
|
86k |
77.00 |
|
Sage Therapeutics Common
(SAGE)
|
0.2 |
$6.5M |
|
114k |
56.81 |
|
Fate Therapeutics Common
(FATE)
|
0.2 |
$6.3M |
|
73k |
86.79 |
|
Align Technology Common
(ALGN)
|
0.2 |
$6.1M |
|
9.9k |
610.98 |
|
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.2 |
$6.0M |
|
608k |
9.90 |
|
Amicus Therapeutics Common
(FOLD)
|
0.2 |
$6.0M |
|
622k |
9.64 |
|
PerkinElmer Common
(RVTY)
|
0.2 |
$5.7M |
|
37k |
154.42 |
|
Steris Shares
(STE)
|
0.2 |
$5.7M |
|
28k |
206.29 |
|
Kura Oncology Common
(KURA)
|
0.2 |
$5.7M |
|
274k |
20.85 |
|
Reata Pharmaceuticals Class A
|
0.2 |
$5.4M |
|
38k |
141.53 |
|
Aurinia Pharmaceuticals Common
(AUPH)
|
0.2 |
$5.2M |
|
398k |
12.96 |
|
Trillium Therapeutics Common
|
0.2 |
$5.1M |
|
529k |
9.70 |
|
Healthpeak Properties Common
(DOC)
|
0.2 |
$5.0M |
|
150k |
33.29 |
|
Verona Pharma Sponsored ADR
(VRNA)
|
0.2 |
$4.9M |
|
752k |
6.54 |
|
Centene Corp. Common
(CNC)
|
0.2 |
$4.9M |
|
67k |
72.92 |
|
Addus HomeCare Corp. Common
(ADUS)
|
0.2 |
$4.7M |
|
54k |
87.25 |
|
Smith & Nephew Shares
(SNN)
|
0.2 |
$4.7M |
|
108k |
43.44 |
|
Personalis Common
(PSNL)
|
0.1 |
$4.5M |
|
180k |
25.30 |
|
R1 RCM Common
|
0.1 |
$4.5M |
|
202k |
22.24 |
|
Cogent Biosciences Common
(COGT)
|
0.1 |
$4.4M |
|
538k |
8.11 |
|
Sanofi Sponsored ADR
(SNY)
|
0.1 |
$4.3M |
|
82k |
52.66 |
|
PRA Health Sciences Common
|
0.1 |
$4.1M |
|
25k |
165.19 |
|
Ardelyx Common
(ARDX)
|
0.1 |
$4.1M |
|
539k |
7.58 |
|
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.1 |
$4.1M |
|
48k |
83.77 |
|
TCR2 Therapeutics Common
|
0.1 |
$3.9M |
|
236k |
16.41 |
|
Vir Biotechnology Common
(VIR)
|
0.1 |
$3.8M |
|
81k |
47.28 |
|
Forma Therapeutics Holdings Shares
|
0.1 |
$3.7M |
|
150k |
24.89 |
|
Arcutis Biotherapeutics Common
(ARQT)
|
0.1 |
$3.6M |
|
132k |
27.29 |
|
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$3.5M |
|
210k |
16.83 |
|
Bio-Techne Corp. Common
(TECH)
|
0.1 |
$3.4M |
|
7.6k |
450.26 |
|
Medpace Holdings Common
(MEDP)
|
0.1 |
$3.3M |
|
19k |
176.62 |
|
Mereo BioPharma Group Ads
(MREO)
|
0.1 |
$3.3M |
|
1.0M |
3.17 |
|
Xenon Pharmaceuticals Common
(XENE)
|
0.1 |
$3.1M |
|
169k |
18.62 |
|
Scholar Rock Holding Corp. Common
(SRRK)
|
0.1 |
$3.1M |
|
109k |
28.90 |
|
Healthcare Realty Trust Common
|
0.1 |
$3.1M |
|
104k |
30.20 |
|
Travere Therapeutics Common
(TVTX)
|
0.1 |
$3.1M |
|
213k |
14.59 |
|
Nektar Therapeutics Common
|
0.1 |
$3.1M |
|
180k |
17.16 |
|
Atreca Class A Common
(BCEL)
|
0.1 |
$3.0M |
|
352k |
8.52 |
|
Koninklijke Philips NY Reg Sh
(PHG)
|
0.1 |
$2.8M |
|
57k |
49.70 |
|
Insmed Common
(INSM)
|
0.1 |
$2.8M |
|
98k |
28.46 |
|
Jounce Therapeutics Common
|
0.1 |
$2.6M |
|
382k |
6.80 |
|
Helix Acquisition Corp. Class A Common
|
0.1 |
$2.6M |
|
250k |
10.33 |
|
Global Medical REIT Common
|
0.1 |
$2.6M |
|
175k |
14.76 |
|
Dicerna Pharmaceuticals Common
|
0.1 |
$2.5M |
|
68k |
37.31 |
|
Endo International Shares
|
0.1 |
$2.5M |
|
532k |
4.68 |
|
KalVista Pharmaceuticals Common
(KALV)
|
0.1 |
$2.4M |
|
100k |
23.96 |
|
Perrigo Shares
(PRGO)
|
0.1 |
$2.3M |
|
51k |
45.86 |
|
New Senior Investment Group Common
|
0.1 |
$2.3M |
|
256k |
8.78 |
|
Hologic Common
(HOLX)
|
0.1 |
$2.2M |
|
33k |
66.73 |
|
Healthcare Trust of America Common
|
0.1 |
$1.9M |
|
71k |
26.70 |
|
Vectivbio Holding Ord Shares
|
0.1 |
$1.7M |
|
145k |
11.66 |
|
Organon & Co. Common
(OGN)
|
0.1 |
$1.6M |
|
54k |
30.26 |
|
Black Diamond Therapeutics Common
(BDTX)
|
0.1 |
$1.6M |
|
132k |
12.19 |
|
MorphoSys Sponsored ADS
(MOR)
|
0.1 |
$1.6M |
|
82k |
19.25 |
|
Community Health Systems Common
(CYH)
|
0.1 |
$1.6M |
|
102k |
15.44 |
|
Molecular Templates Common
|
0.1 |
$1.6M |
|
199k |
7.82 |
|
Intercept Pharmaceuticals Common
|
0.1 |
$1.5M |
|
77k |
19.97 |
|
Zogenix Common
|
0.0 |
$1.5M |
|
89k |
17.29 |
|
Diversified Healthcare Trust Common
(DHC)
|
0.0 |
$1.5M |
|
358k |
4.18 |
|
Ovid Therapeutics Sponsored ADR
(OVID)
|
0.0 |
$1.5M |
|
373k |
3.91 |
|
Praxis Precision Medicines Common
|
0.0 |
$1.4M |
|
75k |
18.28 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
0.0 |
$1.3M |
|
13k |
97.38 |
|
ChemoCentryx Common
|
0.0 |
$1.0M |
|
78k |
13.39 |
|
1Life Healthcare Common
|
0.0 |
$1.0M |
|
31k |
33.07 |
|
Nkarta Common
(NKTX)
|
0.0 |
$919k |
|
29k |
31.70 |
|
Teleflex Common
(TFX)
|
0.0 |
$884k |
|
2.2k |
401.82 |
|
Editas Medicine Common
(EDIT)
|
0.0 |
$860k |
|
15k |
56.62 |
|
Regenxbio Common
(RGNX)
|
0.0 |
$843k |
|
22k |
38.85 |
|
Grifols Sponsored ADR
(GRFS)
|
0.0 |
$822k |
|
47k |
17.35 |
|
Precision BioSciences Common
|
0.0 |
$789k |
|
63k |
12.52 |
|
Corbus Pharmaceuticals Holdings Common
|
0.0 |
$757k |
|
414k |
1.83 |
|
Gamida Cell Shares
|
0.0 |
$757k |
|
118k |
6.41 |
|
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$707k |
|
15k |
47.45 |
|
Universal Health Realty Income Trust Shares
(UHT)
|
0.0 |
$693k |
|
11k |
61.56 |
|
National Health Investors Common
(NHI)
|
0.0 |
$673k |
|
10k |
67.05 |
|
Assertio Holdings Common
(ASRT)
|
0.0 |
$640k |
|
411k |
1.56 |
|
VYNE Therapeutics Common
|
0.0 |
$475k |
|
135k |
3.51 |
|
Spectrum Pharmaceuticals Common
|
0.0 |
$430k |
|
115k |
3.75 |
|
CymaBay Therapeutics Common
|
0.0 |
$384k |
|
88k |
4.36 |
|
Celldex Therapeutics Common
(CLDX)
|
0.0 |
$236k |
|
7.1k |
33.46 |
|
Five Star Senior Living Common
|
0.0 |
$140k |
|
24k |
5.78 |
|
ARCA biopharma Common
(ABIO)
|
0.0 |
$113k |
|
33k |
3.48 |
|
Bellicum Pharmaceuticals Common
|
0.0 |
$20k |
|
6.0k |
3.33 |
|
Tetraphase Pharmaceuticals Common
|
0.0 |
$5.0k |
|
43k |
0.12 |